Product Code: ANV3020
REPORT HIGHLIGHT
Prosthetic Joint Infection Treatment Market size was valued at USD 188.78 Million in 2023, expanding at a CAGR of 4.6% from 2024 to 2032.
Treatment for prosthetic joint infections (PJIs) focuses on controlling infections in artificial joints, like knee or hip replacements. Because of the formation of biofilms, antibiotic resistance, and the possibility of severe consequences from untreated infections, these infections can be difficult to treat. Depending on the specific needs of each patient, treatment plans often combine medicinal and surgical procedures.
Prosthetic Joint Infection Treatment Market- Market Dynamics
The rising prevalence of joint replacement surgeries and the development of diagnostic techniques are expected to propel market demand
There is an increasing need for joint replacement surgery, such as hip and knee replacements, as the world's population ages and leads different lifestyles which is boosting the market growth. Effective treatment solutions are in high demand as the number of surgeries performed is rising along with the prevalence of prosthetic joint infections. Prosthetic joint infections are not an exception to the worldwide trend of antibiotic resistance. The advent of bacterial strains resistant to antibiotics affects the management of pressure injuries (PJIs) and calls for the creation of novel treatments and treatment approaches.
Prosthetic joint infections can now be detected more quickly and accurately thanks to advancements in diagnostic methods including molecular diagnostic tools and sophisticated imaging modalities. The need for related treatment choices might be influenced by early detection, which is essential for effective therapy. There are now more alternatives for treating prosthetic joint infections thanks to the introduction of newer therapeutic methods such as biofilm-targeting drugs, antibiotic-loaded bone cement, and sophisticated surgical techniques. These developments have the potential to boost market expansion, lower recurrence rates, and enhance treatment outcomes. Together, these factors support the expansion and growth of the prosthetic joint infection treatment industry.
Prosthetic Joint Infection Treatment Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.6% over the forecast period (2024-2032)
Based on Type segmentation, the fusidic acid segment was predicted to show maximum market share in the year 2023, owing to its high effectiveness in PJI treatment.
Based on Application segmentation, the clinical segment was the leading Application in 2023, due to high demand in clinical operations.
Based on End User segmentation, the hospital segment was the leading End User in 2023, owing to the high prevalence of PJI related surgery treatment at hospitals.
Based on region, North America was the leading revenue generator in 2023, owing to growing surgery & high demand for PJI treatment.
Prosthetic Joint Infection Treatment Market- Segmentation Analysis:
The Global Prosthetic Joint Infection Treatment Market is segmented based on Type, Application, End User, and Region.
The market is divided into five categories based on Type: fusidic acid, Lefamulin acetate, MTF-101, TNP-2092, and others. The fusidic acid segment dominates the market. Fusidic acid is highly effective in treating PJI related disorders.
The market is divided into three categories based on the Application: clinical, medical procedures, and others. The clinical segment dominates the market. The growing need for orthopedic practices, and joint replacement surgeries, is fueling market growth.
The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. High prevalence of joint related surgeries, orthopedic surgery disorders are augmenting the segment growth.
Prosthetic Joint Infection Treatment Market- Geographical Insights
Globally, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is expected to be a significant contributor to the PJI treatment market due to factors such as a high prevalence of joint replacement surgeries, advanced healthcare infrastructure, and a strong focus on medical innovation. The United States, in particular, accounts for a substantial share of the global market. Latin America is emerging as a promising market for PJI treatment, supported by improving healthcare infrastructure.
Prosthetic Joint Infection Treatment Market- Competitive Landscape:
The Prosthetic Joint Infection Treatment market is made up of small & large market participants. Market players have been investing in research and development to enhance their portfolio of PJI treatment solutions. Recent developments include the introduction of advanced implant materials designed to reduce the risk of infection and improve patient outcomes. Companies also focus on offering a range of products for PJI treatment, including antimicrobial dressings, wound care solutions, and surgical instruments.
Recent Developments:
In June 2024, Osteal Therapeutics raised USD 50 million in Series D investment, as the orthopedic infection treatment specialist wants to expand their business.
In August 2022, Armata Pharmaceuticals announced approval of its new drug application AP-SA02 in prosthetic joint infection (PJI).
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PROSTHETIC JOINT INFECTION TREATMENT MARKET KEY PLAYERS
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- Johnson & Johnson (DePuy Synthes)
- Smith & Nephew plc
- Bioventus LLC
- ConvaTec Group plc
- Becton, Dickinson and Company
- Heraeus Holding GmbH
- Medtronic plc
- B. Braun Melsungen AG
- Molnlycke Health Care AB
- Merck & Co., Inc.
- Osteal Therapeutics
- Integra LifeSciences Holdings Corporation
- Armata Pharmaceuticals
- Arthrex, Inc.
- Others
GLOBAL PROSTHETIC JOINT INFECTION TREATMENT MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032
- Fusidic acid
- Lefamulin acetate
- MTF-101
- TNP-2092
- Others
GLOBAL PROSTHETIC JOINT INFECTION TREATMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
- Clinical
- Medical procedures
- Others
GLOBAL PROSTHETIC JOINT INFECTION TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
GLOBAL PROSTHETIC JOINT INFECTION TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Prosthetic Joint Infection Treatment Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Prosthetic Joint Infection Treatment Market Snippet by Type
- 2.1.2. Prosthetic Joint Infection Treatment Market Snippet by Application
- 2.1.3. Prosthetic Joint Infection Treatment Market Snippet by End User
- 2.1.4. Prosthetic Joint Infection Treatment Market Snippet by Country
- 2.1.5. Prosthetic Joint Infection Treatment Market Snippet by Region
- 2.2. Competitive Insights
3. Prosthetic Joint Infection Treatment Key Market Trends
- 3.1. Prosthetic Joint Infection Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Prosthetic Joint Infection Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Prosthetic Joint Infection Treatment Market Opportunities
- 3.4. Prosthetic Joint Infection Treatment Market Future Trends
4. Prosthetic Joint Infection Treatment Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Prosthetic Joint Infection Treatment Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Prosthetic Joint Infection Treatment Market Landscape
- 6.1. Prosthetic Joint Infection Treatment Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Prosthetic Joint Infection Treatment Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 7.1.2. Fusidic acid
- 7.1.3. Lefamulin acetate
- 7.1.4. MTF-101
- 7.1.5. TNP-2092
- 7.1.6. Others
8. Prosthetic Joint Infection Treatment Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Clinical
- 8.1.3. Medical procedures
- 8.1.4. Others
9. Prosthetic Joint Infection Treatment Market - By End User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Clinics
- 9.1.4. Others
10. Prosthetic Joint Infection Treatment Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Prosthetic Joint Infection Treatment Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Prosthetic Joint Infection Treatment Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Prosthetic Joint Infection Treatment Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Prosthetic Joint Infection Treatment Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Prosthetic Joint Infection Treatment Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Prosthetic Joint Infection Treatment Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Zimmer Biomet Holdings, Inc.
- 11.2.2. Stryker Corporation
- 11.2.3. Johnson & Johnson (DePuy Synthes)
- 11.2.4. Smith & Nephew plc
- 11.2.5. Bioventus LLC
- 11.2.6. ConvaTec Group plc
- 11.2.7. Becton, Dickinson and Company
- 11.2.8. Heraeus Holding GmbH
- 11.2.9. Medtronic plc
- 11.2.10. B. Braun Melsungen AG
- 11.2.11. Molnlycke Health Care AB
- 11.2.12. Merck & Co., Inc.
- 11.2.13. Osteal Therapeutics
- 11.2.14. Integra LifeSciences Holdings Corporation
- 11.2.15. Armata Pharmaceuticals
- 11.2.16. Arthrex, Inc.
- 11.2.17. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us